IDO1 and melanoma: It has been reported that up-regulation of IDO1 in metastatic malignant melanoma cells and metastatic pancreatic ductal adenocarcinoma cells was associated with an increased number of regulatory T cells (Tregs) and shorter survival [8, 9].